Ezhilarasan D, Evraerts J, Brice S, BucCalderon P, Karthikeyan S, Sokal E,
Najimi M. 2016. Silibinin inhibits
proliferation and migration of human
hepatic stellate LX-2 cells. J Clin Exp
Hepatol, 6: 167-174.
Ezhilarasan D. 2018. Oxidative stress is bane in
chronic liver diseases: Clinical and
experimental perspective. Arab J
Gastroenterol, 19: 56-64.
Hejazian SM, Hosseiniyan Khatibi SM,
Barzegari A, Pavon-Djavid G, Razi
Soofiyani S, Hassannejhad S, Ahmadian
E, Ardalan M, Zununi Vahed S. 2021. Nrf2 as a therapeutic target in acute kidney
injury. Life Sci, 264: 118581.
Li JP, Gao Y, Chu SF, Zhang Z, Xia CY, Mou
Z, Song XY, He WB, Guo XF, Chen NH.
2014. Nrf2 pathway activation contributes
to anti-fibrosis effects of ginsenoside Rg1
in a rat model of alcohol- and CCl4-
induced hepatic fibrosis. Acta Pharmacol
Sin, 35: 1031-1044.
Robledinos-Antón N, Fernández-Ginés R,
Manda G, Cuadrado A. 2019. Activators
and inhibitors of NRF2: A review of their
potential for clinical development. Oxid
Med Cell Longev, 2019: 9372182.
Shanmugam S, Patel D, Wolpert JM, Keshvani
C, Liu X, Bergeson SE, Kidambi S,
Mahimainathan L, Henderson GI,
Narasimhan M. 2019. Ethanol impairs
NRF2/antioxidant and growth signaling in
the intact placenta in vivo and in human
trophoblasts. Biomolecules 9: 669.
Sueblinvong V, Tseng V, Smith T, Saghafi R,
Mills ST, Neujahr DC, Guidot DM. 2014.
TGFβ1 mediates alcohol-induced Nrf2
suppression in lung fibroblasts. Alcohol
Clin Exp Res, 38: 2731-2742.
Zhao N, Guo FF, Xie KQ, Zeng T. 2018.
Targeting Nrf-2 is a promising
intervention approach for the prevention of
ethanol-induced liver disease. Cell Mol
Life Sci 75: 3143-3157